AMAGASAKI Taro | Novartis Pharma Japan
スポンサーリンク
概要
関連著者
-
AMAGASAKI Taro
Novartis Pharma Japan
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Usubuchi Noriko
国立がんセンター中央病院
-
Usubuchi Noriko
Hematology And Oncology Division National Cancer Center Hospital East
著作論文
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Good Prognosis of Patients With Acute Promyelocytic Leukemia Who Achieved Second Complete Remission (CR) With a New Retinoid, Am80, After Relapse From CR Induced by All-trans-Retionic Acid
- Multicenter Prospective Study of Interferon-α and Conventional Chemotherapy Versus Bone Marrow Transplantation for Newly Diagnosed Patients With Chronic Myelogenous Leukemia
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Spicamycin and KRN5500 Induce Apoptosis in Myeloid and Lymphoid Cell Lines with Down-regulation of Bcl-2 Expression and Modulation of Promyelocytic Leukemia Protein
- Relapse in the External Auditory Canal of Acute Promyelocytic Leukemia after Treatment with All-Trans Retinoic Acid
- New Flow Cytometric Method for Detection of Minimally Expressed Multidrug Resistance P-Glycoprotein on Normal and Acute Leukemia Cells Using Biotinylated MRK16 and Streptavidin-RED670 Conjugate